
Organovo Holdings ONVO
Quarterly report 2025-Q4
added 02-11-2026
Organovo Holdings EV/EBITDA Ratio 2011-2026 | ONVO
Annual EV/EBITDA Ratio Organovo Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.992 | -1.32 | -3 | -2.62 | -5.9 | -5 | -10.4 | -18.7 | -1.37 K | -18.6 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.992 | -1.37 K | -144 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
27.4 | $ 118.37 | -1.17 % | $ 36 B | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 20.14 | -2.04 % | $ 217 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 525.26 | 1.3 % | $ 15.2 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 22.07 | 25.61 % | $ 1.18 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.14 | -6.22 % | $ 1.04 B | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.26 | -1.7 % | $ 2.01 B | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 28.88 | -0.65 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 1.42 | - | $ 1.89 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 24.4 | -0.89 % | $ 678 M | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.78 | -1.81 % | $ 283 M | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 52.59 | 0.03 % | $ 2.67 B | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Neuronetics
STIM
|
-1.45 | $ 1.41 | 1.08 % | $ 93 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 180.6 | 0.02 % | $ 8.95 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 520.64 | -2.04 % | $ 196 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 194.14 | -2.02 % | $ 138 B | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 2.2 | - | $ 9.73 M | ||
|
Trinity Biotech plc
TRIB
|
12.6 | $ 0.7 | -0.91 % | $ 61.9 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 56.1 | -2.65 % | $ 3.36 B | ||
|
Illumina
ILMN
|
70.5 | $ 131.42 | -0.64 % | $ 20.9 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 16.12 | -0.31 % | $ 487 M | ||
|
Guardant Health
GH
|
-28.8 | $ 84.82 | -0.05 % | $ 10.6 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.84 | -3.24 % | $ 92.2 K | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.21 | 4.5 % | $ 5.08 M | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 117.7 | 1.03 % | $ 9.71 B | ||
|
Waters Corporation
WAT
|
24.6 | $ 323.16 | -0.93 % | $ 19.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 267.93 | 0.45 % | $ 22.3 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
-2.38 | $ 124.57 | 0.89 % | $ 5.82 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 5.13 | -1.25 % | $ 475 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 83.18 | -0.91 % | $ 5.61 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 193.13 | 0.89 % | $ 21.4 B |